Clinical Trial Update: A Study of Nipocalimab in Adults With Primary Sjogren's Syndrome (pSS) [Phase 2]

View source ↗

Summary

This update reports the completion of a Phase 2 study evaluating Nipocalimab in adults with primary Sjögren's syndrome.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Sjögren Syndrome

Drugs mentioned

• Nipocalimab (nipocalimab)

Snippet

Sponsor: Janssen Research & Development, LLC | Conditions: Sjogren's Syndrome | Phase 2 | Status: COMPLETED